UnknownPhase 1NCT02121171

Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma

Studying Congenital glaucoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Centre of Ophthalmology named after academician Zarifa Aliyeva
Principal Investigator
Nigar Makhmudova
Ophthalmologist at National Centre of Ophthalmology
Intervention
Ologen Collagen Matrix(device)
Enrollment
40 enrolled
Eligibility
12 years · All sexes
Timeline
20102015

Study locations (1)

Collaborators

Aeon Astron Europe B.V.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02121171 on ClinicalTrials.gov

Other trials for Congenital glaucoma

Additional recruiting or active studies for the same condition.

See all trials for Congenital glaucoma

← Back to all trials